Trilogy Capital Inc. lifted its holdings in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 40.3% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 6,083 shares of the company's stock after acquiring an additional 1,747 shares during the quarter. Trilogy Capital Inc.'s holdings in Procter & Gamble were worth $1,037,000 as of its most recent SEC filing.
Several other hedge funds have also added to or reduced their stakes in PG. Navigoe LLC acquired a new stake in Procter & Gamble during the 4th quarter worth approximately $31,000. Capital A Wealth Management LLC acquired a new position in Procter & Gamble in the 4th quarter valued at $31,000. Hoey Investments Inc. raised its holdings in Procter & Gamble by 321.7% in the 4th quarter. Hoey Investments Inc. now owns 194 shares of the company's stock valued at $33,000 after acquiring an additional 148 shares in the last quarter. 10Elms LLP acquired a new position in Procter & Gamble in the 4th quarter valued at $34,000. Finally, Sunbeam Capital Management LLC acquired a new position in Procter & Gamble in the 4th quarter valued at $34,000. 65.77% of the stock is owned by institutional investors and hedge funds.
Insider Activity at Procter & Gamble
In related news, insider Moses Victor Javier Aguilar sold 10,520 shares of the company's stock in a transaction dated Monday, May 5th. The stock was sold at an average price of $158.67, for a total transaction of $1,669,208.40. Following the sale, the insider owned 25,182 shares in the company, valued at $3,995,627.94. This represents a 29.47% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 0.18% of the company's stock.
Procter & Gamble Trading Down 1.2%
Shares of NYSE PG traded down $1.92 during trading on Wednesday, reaching $154.69. The company had a trading volume of 1,782,288 shares, compared to its average volume of 8,195,523. The company's fifty day moving average price is $160.68 and its 200-day moving average price is $164.19. Procter & Gamble Company has a 12 month low of $151.90 and a 12 month high of $180.43. The stock has a market cap of $362.67 billion, a P/E ratio of 24.58, a PEG ratio of 4.48 and a beta of 0.40. The company has a quick ratio of 0.50, a current ratio of 0.71 and a debt-to-equity ratio of 0.47.
Procter & Gamble (NYSE:PG - Get Free Report) last released its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 EPS for the quarter, beating analysts' consensus estimates of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.67% and a net margin of 18.46%. The firm had revenue of $20.89 billion for the quarter, compared to analyst estimates of $20.79 billion. During the same quarter in the previous year, the company posted $1.40 EPS. The business's revenue was up 1.7% on a year-over-year basis. As a group, research analysts expect that Procter & Gamble Company will post 6.91 earnings per share for the current year.
Procter & Gamble Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, August 15th. Shareholders of record on Friday, July 18th will be given a $1.0568 dividend. The ex-dividend date is Friday, July 18th. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.73%. Procter & Gamble's dividend payout ratio (DPR) is presently 66.98%.
Wall Street Analyst Weigh In
Several equities analysts have weighed in on the company. Truist Financial dropped their price objective on Procter & Gamble from $185.00 to $180.00 and set a "buy" rating for the company in a report on Friday, April 25th. UBS Group dropped their price objective on Procter & Gamble from $186.00 to $180.00 and set a "buy" rating for the company in a report on Thursday, July 17th. Bank of America dropped their price objective on Procter & Gamble from $190.00 to $180.00 and set a "buy" rating for the company in a report on Friday, April 25th. Piper Sandler boosted their price target on Procter & Gamble from $160.00 to $164.00 and gave the stock a "neutral" rating in a report on Monday, May 5th. Finally, Raymond James Financial lowered their price target on Procter & Gamble from $190.00 to $185.00 and set an "outperform" rating for the company in a report on Friday, April 25th. Nine research analysts have rated the stock with a hold rating, ten have given a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $175.71.
Check Out Our Latest Report on Procter & Gamble
Procter & Gamble Company Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Articles

Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.